Bioequivalence Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets
Status:
NOT_YET_RECRUITING
Trial end date:
2026-07-28
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, two-treatment, two-period crossover study evaluating the bioequivalence of liquid metformin formulations at 100 mg/mL and 250 mg/mL compared with immediate-release metformin tablets in healthy adult subjects. Each participant will receive both treatments in randomized sequence with an adequate washout interval between periods. Serial blood samples will be collected to assess metformin pharmacokinetics, and safety will be monitored throughout the study.